ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

April 19, 2002

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned.

March 14, 2008

Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions.

September 12, 2008

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012